ask="2.81"
ask_size="400"
average_daily_volume="240924"
bid="2.20"
bid_size="500"
book_value="3.15"
change="+0.08"
change_from_200_day_moving_average="-0.01"
change_from_50_day_moving_average="0.46"
change_from_52_week_high="-5.61"
change_From_52_week_low="0.99"
change_in_percent="+3.08%"
close="2.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14677000"
high="2.71"
high_52_weeks="8.29"
last_trade_date="1/18/2017"
last_trade_price="2.68"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.58"
low_52_weeks="1.69"
market_capitalization="54.26M"
moving_average_200_day="2.69"
moving_average_50_day="2.22"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="2.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.27%"
percent_change_from_50_day_moving_average="+20.64%"
percent_change_from_52_week_high="-67.67%"
percent_change_from_52_week_low="+58.58%"
previous_close="2.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.83"
price_per_sales="1.46"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="2.06"
stock_exchange="NMS"
symbol="APVO"
volume="89344"
weeks_range_52="1.69 - 8.29"
